<DOC>
	<DOCNO>NCT01267149</DOCNO>
	<brief_summary>Statistical Hypotheses The Null Hypothesis : There difference reduction line treat area compare baseline . Alternative Hypothesis : There difference reduction line treat area compare baseline .</brief_summary>
	<brief_title>A Clinical Study Evaluaing Efficacy , Safety , Patient Satisfaction Injectable Hylaronic Acid With 0.3 % Lidocain Hydrochloride , Prevelle Silk , Superficial , Vertical Perioral Lines Superficial , Horizontal , Lateral Canthal Lines</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Females male good general health 35 65 year age . Must willing give sign HIPPA form , informed consent form photographic release form Patient planning undergo Prevelle Silk treatment A potential subject 's must exhibit : A. moderate severe superficial , vertical perioral horizontal canthus line For FEMALE PATIENT OF CHILDBEARING POTENTIAL , must regular menstrual cycle prior study entry ( female consider childbearing potential unless postmenopausal , without uterus and/or ovary , bilateral tubal ligation ) willing use acceptable form birth control entire course study [ i.e. , acceptable method birth control oral contraceptive , contraceptive patches/rings/implants Norplanit® , DepoProvena® , doublebarrier method ( e.g . condom spermicide ) , abstinence vasectomy partner document second acceptable method birth control patient become sexually active ] . All systemic birth control measure must consistent use least 30 day prior study participation Negative urine pregnancy test result time study entry ( applicable ) Must willing comply study regimen complete entire course study . A patient UNCONTROLLED systemic disease . A potential patient therapy systemic disease yet stabilize consider entry study A patient significant history current evidence medical , psychological disorder , investigator 's opinion , would preclude enrollment study . A patient know hypersensitivity component study medication A patient actively smoke plan smoke time duration study A patient active skin condition/disease might interfere diagnosis evaluation study parameter ( i.e. , atopic dermatitis , eczema , psoriasis , seborrheic dermatitis , herpes labialis ) A patient planning cosmetic procedure facial area study period , treatment perform investigator A patient use topical ( prescription counter ) medicate cream , lotion , gel , balm , powder , etc . treatment area study period A patient receive topical product contain alphahydroxy acid , salicylic acid , vitamins C D ( include derivative thereof ) perioral lateral canthal area within 7 day prior study period , study product A patient receive investigational drug and/or microdermabrasion ( light medium skin peel ) treatment perioral lateral canthal area within 30 day prior study period A patient use topical tretinoin product derivative perioral lateral canthal area within 12 week prior study period A patient receive chemical peel , systemic steroid , nonablative laser , light radio frequency treatment and/or Dermabrasion ( deep skin peel ) ablative laser treatment perioral lateral canthal area must discontinue drug/treatment and/or procedure least 6 month prior enter study A patient previously treat botulinum toxin perioral lateral canthal area within past six month A patient previously treat dermal filler perioral lateral canthal area within past year A patient history allergic reaction dermal filler lidocaine A patient history permanent filler perioral lateral canthal area A female patient pregnant , nurse infant planning pregnancy study [ throughout course study , woman childbearing potential must use reliable form contraception ( i.e. , oral contraceptive , intrauterine device , abstinence , spermicide condom use combination ) ] Current participation participation within 30 day prior start study drug investigational research study .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>superficial vertical perioral line</keyword>
	<keyword>superficial horizontal lateral canthal line</keyword>
	<keyword>correct moderate severe facial wrinkle fold</keyword>
</DOC>